Frankfurt - Delayed Quote EUR
Ovid Therapeutics Inc. (1OT.F)
0.2260
+0.0300
+(15.31%)
As of 8:06:17 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-55,956
-55,956
-45,781
-55,227.1270
118,611.6730
Investing Cash Flow
54,594
54,594
-2,581
-87,883.2170
-1,821.4000
Financing Cash Flow
622
622
30,535
180.6580
904.0820
End Cash Position
28,232
28,232
28,972
46,798.5990
189,728.2850
Capital Expenditure
-161
-161
-137
-1,418.7760
-189.4080
Free Cash Flow
-56,117
-56,117
-45,918
-56,645.9030
118,422.2650
12/31/2021 - 5/15/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
1VT.MU Viking Therapeutics Inc
22.46
+0.42%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
BCAX Bicara Therapeutics Inc.
15.51
+12.23%
MBX MBX Biosciences, Inc.
8.99
+4.05%
SEPN Septerna, Inc.
6.14
+2.85%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%